+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Allergy Diagnostics Market By Test Type, By Product & Service, By Allergen, By End-user: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 390 Pages
  • September 2022
  • Region: Global
  • Allied Market Research
  • ID: 5713069
The global allergy diagnostic market is envisioned to garner $16,714.2 million by 2031, growing from $4,965.4 million in 2021 at a CAGR of 13.2% from 2022 to 2031.

An allergy is referred to as a systemic sensitivity condition in medical terminology. To assess whether the patient's body is allergic to any known substances, a competent allergy expert will perform an allergy diagnostic test. The diagnosis of allergy is typically made with a diagnostic test or a biopsy.

The main risk factors for developing chronic respiratory disorders are occupational exposure, allergen exposure, and exposure to indoor and outdoor air pollution. Due to the greater exposure to environmental toxins in cities, the prevalence of allergy illnesses is higher among urban residents than rural residents (as a result of vehicular pollution and industrial activities). Although this is a worldwide trend, its impacts are more severe in the metropolitan regions of low-income nations, where more than 80% of people live in locations where air quality levels exceed WHO (World Health Organization) safety guidelines. Given that air pollution from automobiles has been identified as one of the key risk factors contributing to allergic disorders, this is a significant signal for the market growth for allergy diagnostic. Asthma, allergic rhinitis, and other allergy illnesses are more common when there is air pollution, according to epidemiological and toxicological study. Studies have also shown a considerable rise in the prevalence and severity of asthma attacks in metropolitan areas with high concentrations of ozone, nitrogen dioxide, and PM 2.5 (particulate matter having a diameter of 2.5 micrometers or smaller). Members of the allergy and immunology communities have conducted studies that demonstrate how pollutants enhance early and late allergic reactions.

On the other side, it is also anticipated that the rising price of allergy diagnostic equipment would restrain the market expansion over the projected time frame. The shortage of allergists, however, may provide further difficulties for the development of the allergy diagnostic industry in the near future.

The market for allergy diagnostic is predicted to have lucrative opportunities due to the growing adoption of mHealth apps. The use of mHealth for rhinitis diagnosis is currently restricted since there are so few mHealth tools for Allergic Rhinitis (AR) diagnosis that have been published in peer-reviewed publications. Recent developments in integrated biosensors, wireless connectivity, and power harvesting methods have given rise to a new generation of point-of-care gadgets.

Due to the global COVID outbreak, there was a little reduction in the market for allergy diagnostics. Given that affected patients are well-instructed about avoiding potential environmental triggers and treating acute events, also based on written action plans, diagnostic procedures were postponed in the majority of allergic diseases. However, once the pandemic was under control, the diagnostic processes resumed.

The key players profiled in this report include Thermo Fisher Scientific, PerkinElmer Inc., Danaher, Hitachi Chemicals, BIOMÉRIEUX, Omega Diagnostics Group PLC, Siemens, Eurofins Scientific, Stallergenes Greer, and Neogen Corporation.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the allergy diagnostic market analysis from 2021 to 2031 to identify the prevailing allergy diagnostic market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the allergy diagnostic market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global allergy diagnostic market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Test Type

  • In Vitro
  • In Vivo

By Product Service

  • Consumables
  • Instruments
  • Services

By Allergen

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Other Allergens

By End-user

  • Diagnostic Laboratories
  • Hospital-based Laboratories
  • Academic Research Institutes
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • United Arab Emirates
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Alerchek Inc.
  • Danaher Corp
  • Hitachi chemical Diagnostic Inc.
  • HOB Biotech Group Co. Ltd.
  • Hycor Biomedical Inc.
  • Lincoln Diagnostics Inc.
  • Omega Diagnostic Llc
  • Siemens Healthcare Diagnostics, Inc.
  • Stallergenes SA
  • Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher
  • Omega Diagnostics Group PLC
  • Eurofins Scientific
  • bioMérieux SA
  • HollisterStier Allergy
  • Minaris Medical America, Inc.
  • ACON Laboratories, Inc.
  • Lincoln Diagnostics, Inc.
  • Neogen Corporation

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
3.7. Value Chain Analysis
3.8. Regulatory Guidelines
3.9. Market Share Analysis
3.10. Key Regulation Analysis
3.11. Patent Landscape

CHAPTER 4: WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 In Vivo
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 In Vitro
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country

CHAPTER 5: WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE
5.1 Overview
5.1.1 Market size and forecast
5.2 Consumables
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Instruments
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Services
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country

CHAPTER 6: WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN
6.1 Overview
6.1.1 Market size and forecast
6.2 Inhaled Allergens
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Food Allergens
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Drug Allergens
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Other Allergens
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country

CHAPTER 7: WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Diagnostic Laboratories
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Hospital-based Laboratories
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Academic Research Institutes
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country

CHAPTER 8: WORLD ALLERGY DIAGNOSTIC MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Test Type
8.2.3 North America Market size and forecast, by Product & Service
8.2.4 North America Market size and forecast, by Allergen
8.2.5 North America Market size and forecast, by End-user
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Test Type
8.2.6.1.2 Market size and forecast, by Product & Service
8.2.6.1.3 Market size and forecast, by Allergen
8.2.6.1.4 Market size and forecast, by End-user
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Test Type
8.2.6.2.2 Market size and forecast, by Product & Service
8.2.6.2.3 Market size and forecast, by Allergen
8.2.6.2.4 Market size and forecast, by End-user
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Test Type
8.2.6.3.2 Market size and forecast, by Product & Service
8.2.6.3.3 Market size and forecast, by Allergen
8.2.6.3.4 Market size and forecast, by End-user
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Test Type
8.3.3 Europe Market size and forecast, by Product & Service
8.3.4 Europe Market size and forecast, by Allergen
8.3.5 Europe Market size and forecast, by End-user
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Test Type
8.3.6.1.2 Market size and forecast, by Product & Service
8.3.6.1.3 Market size and forecast, by Allergen
8.3.6.1.4 Market size and forecast, by End-user
8.3.6.2 UK
8.3.6.2.1 Market size and forecast, by Test Type
8.3.6.2.2 Market size and forecast, by Product & Service
8.3.6.2.3 Market size and forecast, by Allergen
8.3.6.2.4 Market size and forecast, by End-user
8.3.6.3 France
8.3.6.3.1 Market size and forecast, by Test Type
8.3.6.3.2 Market size and forecast, by Product & Service
8.3.6.3.3 Market size and forecast, by Allergen
8.3.6.3.4 Market size and forecast, by End-user
8.3.6.4 Spain
8.3.6.4.1 Market size and forecast, by Test Type
8.3.6.4.2 Market size and forecast, by Product & Service
8.3.6.4.3 Market size and forecast, by Allergen
8.3.6.4.4 Market size and forecast, by End-user
8.3.6.5 Italy
8.3.6.5.1 Market size and forecast, by Test Type
8.3.6.5.2 Market size and forecast, by Product & Service
8.3.6.5.3 Market size and forecast, by Allergen
8.3.6.5.4 Market size and forecast, by End-user
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Test Type
8.3.6.6.2 Market size and forecast, by Product & Service
8.3.6.6.3 Market size and forecast, by Allergen
8.3.6.6.4 Market size and forecast, by End-user
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Test Type
8.4.3 Asia-Pacific Market size and forecast, by Product & Service
8.4.4 Asia-Pacific Market size and forecast, by Allergen
8.4.5 Asia-Pacific Market size and forecast, by End-user
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Test Type
8.4.6.1.2 Market size and forecast, by Product & Service
8.4.6.1.3 Market size and forecast, by Allergen
8.4.6.1.4 Market size and forecast, by End-user
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Test Type
8.4.6.2.2 Market size and forecast, by Product & Service
8.4.6.2.3 Market size and forecast, by Allergen
8.4.6.2.4 Market size and forecast, by End-user
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Test Type
8.4.6.3.2 Market size and forecast, by Product & Service
8.4.6.3.3 Market size and forecast, by Allergen
8.4.6.3.4 Market size and forecast, by End-user
8.4.6.4 South Korea
8.4.6.4.1 Market size and forecast, by Test Type
8.4.6.4.2 Market size and forecast, by Product & Service
8.4.6.4.3 Market size and forecast, by Allergen
8.4.6.4.4 Market size and forecast, by End-user
8.4.6.5 Australia
8.4.6.5.1 Market size and forecast, by Test Type
8.4.6.5.2 Market size and forecast, by Product & Service
8.4.6.5.3 Market size and forecast, by Allergen
8.4.6.5.4 Market size and forecast, by End-user
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Test Type
8.4.6.6.2 Market size and forecast, by Product & Service
8.4.6.6.3 Market size and forecast, by Allergen
8.4.6.6.4 Market size and forecast, by End-user
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Test Type
8.5.3 LAMEA Market size and forecast, by Product & Service
8.5.4 LAMEA Market size and forecast, by Allergen
8.5.5 LAMEA Market size and forecast, by End-user
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Test Type
8.5.6.1.2 Market size and forecast, by Product & Service
8.5.6.1.3 Market size and forecast, by Allergen
8.5.6.1.4 Market size and forecast, by End-user
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Test Type
8.5.6.2.2 Market size and forecast, by Product & Service
8.5.6.2.3 Market size and forecast, by Allergen
8.5.6.2.4 Market size and forecast, by End-user
8.5.6.3 United Arab Emirates
8.5.6.3.1 Market size and forecast, by Test Type
8.5.6.3.2 Market size and forecast, by Product & Service
8.5.6.3.3 Market size and forecast, by Allergen
8.5.6.3.4 Market size and forecast, by End-user
8.5.6.4 South Africa
8.5.6.4.1 Market size and forecast, by Test Type
8.5.6.4.2 Market size and forecast, by Product & Service
8.5.6.4.3 Market size and forecast, by Allergen
8.5.6.4.4 Market size and forecast, by End-user
8.5.6.5 Rest of LAMEA
8.5.6.5.1 Market size and forecast, by Test Type
8.5.6.5.2 Market size and forecast, by Product & Service
8.5.6.5.3 Market size and forecast, by Allergen
8.5.6.5.4 Market size and forecast, by End-user

CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES
10.1 Alerchek Inc.
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Danaher Corp
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Hitachi chemical Diagnostic Inc.
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 HOB Biotech Group Co. Ltd.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Hycor Biomedical Inc.
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Lincoln Diagnostics Inc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Omega Diagnostic Llc
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Siemens Healthcare Diagnostics, Inc.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Stallergenes SA
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Thermo Fisher Scientific Inc.
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 Thermo Fisher Scientific Inc.
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 Danaher
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 Omega Diagnostics Group PLC
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 Eurofins Scientific
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 bioMérieU.S.
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
10.16 HollisterStier Allergy
10.16.1 Company overview
10.16.2 Company snapshot
10.16.3 Operating business segments
10.16.4 Product portfolio
10.16.5 Business performance
10.16.6 Key strategic moves and developments
10.17 Minaris Medical America, Inc.
10.17.1 Company overview
10.17.2 Company snapshot
10.17.3 Operating business segments
10.17.4 Product portfolio
10.17.5 Business performance
10.17.6 Key strategic moves and developments
10.18 ACON Laboratories, Inc.
10.18.1 Company overview
10.18.2 Company snapshot
10.18.3 Operating business segments
10.18.4 Product portfolio
10.18.5 Business performance
10.18.6 Key strategic moves and developments
10.19 Lincoln Diagnostics, Inc.
10.19.1 Company overview
10.19.2 Company snapshot
10.19.3 Operating business segments
10.19.4 Product portfolio
10.19.5 Business performance
10.19.6 Key strategic moves and developments
10.20 Neogen Corporation
10.20.1 Company overview
10.20.2 Company snapshot
10.20.3 Operating business segments
10.20.4 Product portfolio
10.20.5 Business performance
10.20.6 Key strategic moves and developments

List of Tables
Table 1. Global World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 2. World Allergy Diagnostic Market Size, for in Vivo, by Region, 2021-2031 ($Million)
Table 3. World Allergy Diagnostic Market for in Vivo, by Country, 2021-2031 ($Million)
Table 4. World Allergy Diagnostic Market Size, for in Vitro, by Region, 2021-2031 ($Million)
Table 5. World Allergy Diagnostic Market for in Vitro, by Country, 2021-2031 ($Million)
Table 6. Global World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 7. World Allergy Diagnostic Market Size, for Consumables, by Region, 2021-2031 ($Million)
Table 8. World Allergy Diagnostic Market for Consumables, by Country, 2021-2031 ($Million)
Table 9. World Allergy Diagnostic Market Size, for Instruments, by Region, 2021-2031 ($Million)
Table 10. World Allergy Diagnostic Market for Instruments, by Country, 2021-2031 ($Million)
Table 11. World Allergy Diagnostic Market Size, for Services, by Region, 2021-2031 ($Million)
Table 12. World Allergy Diagnostic Market for Services, by Country, 2021-2031 ($Million)
Table 13. Global World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 14. World Allergy Diagnostic Market Size, for Inhaled Allergens, by Region, 2021-2031 ($Million)
Table 15. World Allergy Diagnostic Market for Inhaled Allergens, by Country, 2021-2031 ($Million)
Table 16. World Allergy Diagnostic Market Size, for Food Allergens, by Region, 2021-2031 ($Million)
Table 17. World Allergy Diagnostic Market for Food Allergens, by Country, 2021-2031 ($Million)
Table 18. World Allergy Diagnostic Market Size, for Drug Allergens, by Region, 2021-2031 ($Million)
Table 19. World Allergy Diagnostic Market for Drug Allergens, by Country, 2021-2031 ($Million)
Table 20. World Allergy Diagnostic Market Size, for Other Allergens, by Region, 2021-2031 ($Million)
Table 21. World Allergy Diagnostic Market for Other Allergens, by Country, 2021-2031 ($Million)
Table 22. Global World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 23. World Allergy Diagnostic Market Size, for Diagnostic Laboratories, by Region, 2021-2031 ($Million)
Table 24. World Allergy Diagnostic Market for Diagnostic Laboratories, by Country, 2021-2031 ($Million)
Table 25. World Allergy Diagnostic Market Size, for Hospital-based Laboratories, by Region, 2021-2031 ($Million)
Table 26. World Allergy Diagnostic Market for Hospital-based Laboratories, by Country, 2021-2031 ($Million)
Table 27. World Allergy Diagnostic Market Size, for Academic Research Institutes, by Region, 2021-2031 ($Million)
Table 28. World Allergy Diagnostic Market for Academic Research Institutes, by Country, 2021-2031 ($Million)
Table 29. World Allergy Diagnostic Market Size, for Others, by Region, 2021-2031 ($Million)
Table 30. World Allergy Diagnostic Market for Others, by Country, 2021-2031 ($Million)
Table 31. World Allergy Diagnostic Market, by Region, 2021-2031 ($Million)
Table 32. North America World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 33. North America World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 34. North America World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 35. North America World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 36. North America World Allergy Diagnostic Market, by Country, 2021-2031 ($Million)
Table 37. U.S. World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 38. U.S. World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 39. U.S. World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 40. U.S. World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 41. Canada World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 42. Canada World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 43. Canada World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 44. Canada World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 45. Mexico World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 46. Mexico World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 47. Mexico World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 48. Mexico World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 49. Europe World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 50. Europe World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 51. Europe World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 52. Europe World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 53. Europe World Allergy Diagnostic Market, by Country, 2021-2031 ($Million)
Table 54. Germany World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 55. Germany World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 56. Germany World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 57. Germany World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 58. UK World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 59. UK World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 60. UK World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 61. UK World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 62. France World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 63. France World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 64. France World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 65. France World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 66. Spain World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 67. Spain World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 68. Spain World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 69. Spain World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 70. Italy World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 71. Italy World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 72. Italy World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 73. Italy World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 74. Rest of Europe World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 75. Rest of Europe World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 76. Rest of Europe World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 77. Rest of Europe World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 78. Asia-Pacific World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 79. Asia-Pacific World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 80. Asia-Pacific World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 81. Asia-Pacific World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 82. Asia-Pacific World Allergy Diagnostic Market, by Country, 2021-2031 ($Million)
Table 83. China World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 84. China World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 85. China World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 86. China World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 87. Japan World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 88. Japan World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 89. Japan World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 90. Japan World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 91. India World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 92. India World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 93. India World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 94. India World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 95. South Korea World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 96. South Korea World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 97. South Korea World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 98. South Korea World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 99. Australia World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 100. Australia World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 101. Australia World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 102. Australia World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 103. Rest of Asia-Pacific World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 104. Rest of Asia-Pacific World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 105. Rest of Asia-Pacific World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 106. Rest of Asia-Pacific World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 107. LAMEA World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 108. LAMEA World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 109. LAMEA World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 110. LAMEA World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 111. LAMEA World Allergy Diagnostic Market, by Country, 2021-2031 ($Million)
Table 112. Brazil World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 113. Brazil World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 114. Brazil World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 115. Brazil World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 116. Saudi Arabia World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 117. Saudi Arabia World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 118. Saudi Arabia World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 119. Saudi Arabia World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 120. United Arab Emirates World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 121. United Arab Emirates World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 122. United Arab Emirates World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 123. United Arab Emirates World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 124. South Africa World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 125. South Africa World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 126. South Africa World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 127. South Africa World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 128. Rest of LAMEA World Allergy Diagnostic Market, by Test Type, 2021-2031 ($Million)
Table 129. Rest of LAMEA World Allergy Diagnostic Market, by Product & Service, 2021-2031 ($Million)
Table 130. Rest of LAMEA World Allergy Diagnostic Market, by Allergen, 2021-2031 ($Million)
Table 131. Rest of LAMEA World Allergy Diagnostic Market, by End-user, 2021-2031 ($Million)
Table 132. Alerchek Inc.: Company Snapshot
Table 133. Alerchek Inc.: Operating Segments
Table 134. Alerchek Inc.: Product Portfolio
Table 135. Alerchek Inc.: Net Sales
Table 136. Alerchek Inc.: Key Strategies
Table 137. Danaher Corp: Company Snapshot
Table 138. Danaher Corp: Operating Segments
Table 139. Danaher Corp: Product Portfolio
Table 140. Danaher Corp: Net Sales
Table 141. Danaher Corp: Key Strategies
Table 142. Hitachi Chemical Diagnostic Inc.: Company Snapshot
Table 143. Hitachi Chemical Diagnostic Inc.: Operating Segments
Table 144. Hitachi Chemical Diagnostic Inc.: Product Portfolio
Table 145. Hitachi Chemical Diagnostic Inc.: Net Sales
Table 146. Hitachi Chemical Diagnostic Inc.: Key Strategies
Table 147. Hob Biotech Group Co. Ltd.: Company Snapshot
Table 148. Hob Biotech Group Co. Ltd.: Operating Segments
Table 149. Hob Biotech Group Co. Ltd.: Product Portfolio
Table 150. Hob Biotech Group Co. Ltd.: Net Sales
Table 151. Hob Biotech Group Co. Ltd.: Key Strategies
Table 152. Hycor Biomedical Inc.: Company Snapshot
Table 153. Hycor Biomedical Inc.: Operating Segments
Table 154. Hycor Biomedical Inc.: Product Portfolio
Table 155. Hycor Biomedical Inc.: Net Sales
Table 156. Hycor Biomedical Inc.: Key Strategies
Table 157. Lincoln Diagnostics Inc.: Company Snapshot
Table 158. Lincoln Diagnostics Inc.: Operating Segments
Table 159. Lincoln Diagnostics Inc.: Product Portfolio
Table 160. Lincoln Diagnostics Inc.: Net Sales
Table 161. Lincoln Diagnostics Inc.: Key Strategies
Table 162. Omega Diagnostic LLC: Company Snapshot
Table 163. Omega Diagnostic LLC: Operating Segments
Table 164. Omega Diagnostic LLC: Product Portfolio
Table 165. Omega Diagnostic LLC: Net Sales
Table 166. Omega Diagnostic LLC: Key Strategies
Table 167. Siemens Healthcare Diagnostics, Inc.: Company Snapshot
Table 168. Siemens Healthcare Diagnostics, Inc.: Operating Segments
Table 169. Siemens Healthcare Diagnostics, Inc.: Product Portfolio
Table 170. Siemens Healthcare Diagnostics, Inc.: Net Sales
Table 171. Siemens Healthcare Diagnostics, Inc.: Key Strategies
Table 172. Stallergenes SA: Company Snapshot
Table 173. Stallergenes SA: Operating Segments
Table 174. Stallergenes SA: Product Portfolio
Table 175. Stallergenes SA: Net Sales
Table 176. Stallergenes SA: Key Strategies
Table 177. Thermo Fisher Scientific Inc.: Company Snapshot
Table 178. Thermo Fisher Scientific Inc.: Operating Segments
Table 179. Thermo Fisher Scientific Inc.: Product Portfolio
Table 180. Thermo Fisher Scientific Inc.: Net Sales
Table 181. Thermo Fisher Scientific Inc.: Key Strategies
Table 182. Thermo Fisher Scientific Inc.: Company Snapshot
Table 183. Thermo Fisher Scientific Inc.: Operating Segments
Table 184. Thermo Fisher Scientific Inc.: Product Portfolio
Table 185. Thermo Fisher Scientific Inc.: Net Sales
Table 186. Thermo Fisher Scientific Inc.: Key Strategies
Table 187. Danaher: Company Snapshot
Table 188. Danaher: Operating Segments
Table 189. Danaher: Product Portfolio
Table 190. Danaher: Net Sales
Table 191. Danaher: Key Strategies
Table 192. Omega Diagnostics Group PLC: Company Snapshot
Table 193. Omega Diagnostics Group PLC: Operating Segments
Table 194. Omega Diagnostics Group PLC: Product Portfolio
Table 195. Omega Diagnostics Group PLC: Net Sales
Table 196. Omega Diagnostics Group PLC: Key Strategies
Table 197. Eurofins Scientific: Company Snapshot
Table 198. Eurofins Scientific: Operating Segments
Table 199. Eurofins Scientific: Product Portfolio
Table 200. Eurofins Scientific: Net Sales
Table 201. Eurofins Scientific: Key Strategies
Table 202. BiomérieU.S.: Company Snapshot
Table 203. BiomérieU.S.: Operating Segments
Table 204. BiomérieU.S.: Product Portfolio
Table 205. BiomérieU.S.: Net Sales
Table 206. BiomérieU.S.: Key Strategies
Table 207. Hollisterstier Allergy: Company Snapshot
Table 208. Hollisterstier Allergy: Operating Segments
Table 209. Hollisterstier Allergy: Product Portfolio
Table 210. Hollisterstier Allergy: Net Sales
Table 211. Hollisterstier Allergy: Key Strategies
Table 212. Minaris Medical America, Inc.: Company Snapshot
Table 213. Minaris Medical America, Inc.: Operating Segments
Table 214. Minaris Medical America, Inc.: Product Portfolio
Table 215. Minaris Medical America, Inc.: Net Sales
Table 216. Minaris Medical America, Inc.: Key Strategies
Table 217. Acon Laboratories, Inc.: Company Snapshot
Table 218. Acon Laboratories, Inc.: Operating Segments
Table 219. Acon Laboratories, Inc.: Product Portfolio
Table 220. Acon Laboratories, Inc.: Net Sales
Table 221. Acon Laboratories, Inc.: Key Strategies
Table 222. Lincoln Diagnostics, Inc.: Company Snapshot
Table 223. Lincoln Diagnostics, Inc.: Operating Segments
Table 224. Lincoln Diagnostics, Inc.: Product Portfolio
Table 225. Lincoln Diagnostics, Inc.: Net Sales
Table 226. Lincoln Diagnostics, Inc.: Key Strategies
Table 227. Neogen Corporation: Company Snapshot
Table 228. Neogen Corporation: Operating Segments
Table 229. Neogen Corporation: Product Portfolio
Table 230. Neogen Corporation: Net Sales
Table 231. Neogen Corporation: Key Strategies

List of Figures
Figure 1. World Allergy Diagnostic Market Segmentation
Figure 2. World Allergy Diagnostic Market, 2021-2031
Figure 3. World Allergy Diagnostic Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. World Allergy Diagnostic Mark.:Drivers, Restraints and Opportunities
Figure 12. Value Chain Analysis
Figure 13. Regulatory Guidelines
Figure 14. Market Share Analysis
Figure 15. Key Regulation Analysis
Figure 16. Patent Analysis by Company
Figure 17. Patent Analysis by Country
Figure 18. World Allergy Diagnostic Market, By Test Type, 2021(%)
Figure 19. Comparative Share Analysis of in Vivo World Allergy Diagnostic Market, 2021-2031(%)
Figure 20. Comparative Share Analysis of in Vitro World Allergy Diagnostic Market, 2021-2031(%)
Figure 21. World Allergy Diagnostic Market, By Product & Service, 2021(%)
Figure 22. Comparative Share Analysis of Consumables World Allergy Diagnostic Market, 2021-2031(%)
Figure 23. Comparative Share Analysis of Instruments World Allergy Diagnostic Market, 2021-2031(%)
Figure 24. Comparative Share Analysis of Services World Allergy Diagnostic Market, 2021-2031(%)
Figure 25. World Allergy Diagnostic Market, By Allergen, 2021(%)
Figure 26. Comparative Share Analysis of Inhaled Allergens World Allergy Diagnostic Market, 2021-2031(%)
Figure 27. Comparative Share Analysis of Food Allergens World Allergy Diagnostic Market, 2021-2031(%)
Figure 28. Comparative Share Analysis of Drug Allergens World Allergy Diagnostic Market, 2021-2031(%)
Figure 29. Comparative Share Analysis of Other Allergens World Allergy Diagnostic Market, 2021-2031(%)
Figure 30. World Allergy Diagnostic Market, By End-User, 2021(%)
Figure 31. Comparative Share Analysis of Diagnostic Laboratories World Allergy Diagnostic Market, 2021-2031(%)
Figure 32. Comparative Share Analysis of Hospital-Based Laboratories World Allergy Diagnostic Market, 2021-2031(%)
Figure 33. Comparative Share Analysis of Academic Research Institutes World Allergy Diagnostic Market, 2021-2031(%)
Figure 34. Comparative Share Analysis of Others World Allergy Diagnostic Market, 2021-2031(%)
Figure 35. World Allergy Diagnostic Market by Region, 2021
Figure 36. U.S. World Allergy Diagnostic Market, 2021-2031($Million)
Figure 37. Canada World Allergy Diagnostic Market, 2021-2031($Million)
Figure 38. Mexico World Allergy Diagnostic Market, 2021-2031($Million)
Figure 39. Germany World Allergy Diagnostic Market, 2021-2031($Million)
Figure 40. Uk World Allergy Diagnostic Market, 2021-2031($Million)
Figure 41. France World Allergy Diagnostic Market, 2021-2031($Million)
Figure 42. Spain World Allergy Diagnostic Market, 2021-2031($Million)
Figure 43. Italy World Allergy Diagnostic Market, 2021-2031($Million)
Figure 44. Rest of Europe World Allergy Diagnostic Market, 2021-2031($Million)
Figure 45. China World Allergy Diagnostic Market, 2021-2031($Million)
Figure 46. Japan World Allergy Diagnostic Market, 2021-2031($Million)
Figure 47. India World Allergy Diagnostic Market, 2021-2031($Million)
Figure 48. South Korea World Allergy Diagnostic Market, 2021-2031($Million)
Figure 49. Australia World Allergy Diagnostic Market, 2021-2031($Million)
Figure 50. Rest of Asia-Pacific World Allergy Diagnostic Market, 2021-2031($Million)
Figure 51. Brazil World Allergy Diagnostic Market, 2021-2031($Million)
Figure 52. Saudi Arabia World Allergy Diagnostic Market, 2021-2031($Million)
Figure 53. United Arab Emirates World Allergy Diagnostic Market, 2021-2031($Million)
Figure 54. South Africa World Allergy Diagnostic Market, 2021-2031($Million)
Figure 55. Rest of LAMEA World Allergy Diagnostic Market, 2021-2031($Million)
Figure 56. Top Winning Strategies, by Year
Figure 57. Top Winning Strategies, by Development
Figure 58. Top Winning Strategies, by Company
Figure 59. Product Mapping of Top 10 Players
Figure 60. Competitive Dashboard
Figure 61. Competitive Heatmap of Top 10 Key Players
Figure 62. Alerchek Inc.: Net Sales, ($Million)
Figure 63. Danaher Cor.: Net Sales, ($Million)
Figure 64. Hitachi Chemical Diagnostic Inc.: Net Sales, ($Million)
Figure 65. Hob Biotech Group Co. Ltd.: Net Sales, ($Million)
Figure 66. Hycor Biomedical Inc.: Net Sales, ($Million)
Figure 67. Lincoln Diagnostics Inc.: Net Sales, ($Million)
Figure 68. Omega Diagnostic LL.: Net Sales, ($Million)
Figure 69. Siemens Healthcare Diagnostics, Inc.: Net Sales, ($Million)
Figure 70. Stallergenes S.: Net Sales, ($Million)
Figure 71. Thermo Fisher Scientific Inc.: Net Sales, ($Million)
Figure 72. Thermo Fisher Scientific Inc.: Net Sales, ($Million)
Figure 73. Danahe.: Net Sales, ($Million)
Figure 74. Omega Diagnostics Group pl.: Net Sales, ($Million)
Figure 75. Eurofins Scientifi.: Net Sales, ($Million)
Figure 76. Biomérieux S.: Net Sales, ($Million)
Figure 77. Hollisterstier Allerg.: Net Sales, ($Million)
Figure 78. Minaris Medical America, Inc.: Net Sales, ($Million)
Figure 79. Acon Laboratories, Inc.: Net Sales, ($Million)
Figure 80. Lincoln Diagnostics, Inc.: Net Sales, ($Million)
Figure 81. Neogen Corporatio.: Net Sales, ($Million)

Executive Summary

According to the report, “Allergy Diagnostics Market," the allergy diagnostics market size was valued at $5 billion in 2021, and is estimated to reach $16.7 billion by 2031, growing at a CAGR of 13.2% from 2022 to 2031.

An immune system-driven response or hypersensitivity is known as an allergy. An allergen is a material that triggers allergic responses; such as pollen, pet dander, dust mite secretion, and others. Drug allergies, mold allergies, insect allergies, food allergies, and skin allergies are a few of the most prevalent allergens. Additionally, allergy diagnostic is the test that can identify the kind of allergy and then determine how to treat it. Intradermal, skin-prick, patch, and blood tests are a few of the frequently used methods for diagnosing allergies.

The global market for allergy diagnostics is expanding dramatically, mostly as a result of rising air pollution that can lead to chronic respiratory illnesses. Additionally, according to the WHO (World Health Organization), 80% of people live in metropolitan areas, making them particularly vulnerable to the effects of poor air quality, especially in low-income nations. In addition, several studies have shown a connection between air pollution and allergic rhinitis, asthma, and other conditions, which is fueling the expansion of the allergy diagnostics market growth. Likewise, businesses that are just starting in the allergy diagnostic sector are already setting the pace for other market competitors in terms of developing new customer-focused strategies. For instance, the National Measurement Laboratory (NML) of the UK, introduced the first-ever multi-allergen reference material kit including five common allergens at LGC on February 20, 2020. Egg, milk, walnut, hazelnut, and almond are a few of the typical allergens included in kits. It is also anticipated that market expansion would be fueled by these kinds of activities by industry players.

Due to the high cost of allergy testing equipment, the cost of service is considerable. ELISA analyzers, luminometers, immunoassay analyzers, blot analyzers, and scanners are a few examples of frequently used diagnostic tools. Additionally, the price of an immunoassay analyzer is $10,000, while fully automated analyzers cost around $14,000 each. Such equipment also needs upkeep, lab supervision, operational costs, and other things. In the upcoming years, all of these factors are projected to reduce the market value of allergy diagnostics.

Due to the rapid expansion of the global allergy diagnostics industry, researchers and scientists have accelerated their R&D efforts to create cutting-edge technological gadgets for better allergy diagnostic usage on mobile phones. Additionally, using motion sensors, messaging, cameras, and video calls can aid allergists in communicating with their patients, thanks to the integration of mHealth in allergy diagnostics. As a result, allergy diagnostic via mobile health tools aids clinicians in determining the severity of allergies through the documenting of symptoms, favorably influencing the market expansion. Leading companies in the allergy diagnostic sector are already using innovative customer-drawing tactics. For instance, the ‘ExAller dust mite allergy self-test was introduced by the healthcare business Acar'Up Consumer Health, located in Belgium. This testing kit enables the patient to do a self-test at home in five minutes by identifying specific antibodies in the blood caused by the immune system reacting to a dust particle. The company's current complement of items has complete clinical certification. All of these factors might also result in profitable market prospects for major firms in the coming years.

The global allergy diagnostics market is segmented based on test type, product/service, allergen, end-user, and region. By test type, it is classified into in vivo and in vitro. By product/service, it is classified into consumables, instruments, and services. Allergen, it is classified into inhaled allergens, food allergens, drug allergens, and other allergens. By end-user, it is classified into diagnostic laboratories, hospital-based laboratories, academic research institutes, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in the allergy diagnostic market report include Thermo Fisher Scientific, PerkinElmer Inc., Danaher, Hitachi Chemicals, BIOMÉRIEUX, Omega Diagnostics Group PLC, Siemens, Eurofins Scientific, Stallergenes Greer, and Neogen Corporation.

The report offers a comprehensive analysis of the global allergy diagnostics market trends by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market. The report also sheds light on the present scenario and upcoming trends & developments that are contributing to the growth of the allergy diagnostics market size. Moreover, restraints and challenges that hold power to obstruct the market growth are also profiled in the report along with Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and the emergence of substitutes in the market.

Impact of COVID-19 on the Global Allergy Diagnostic Industry

The novel coronavirus pandemic had a severe impact on a number of businesses, including the market for allergy diagnostic, which experienced a decline during this time.

Additionally, during the COVID-19 outbreak, allergists all around the world are favoring the use of telemedicine for treating rhinitis and asthma. Therefore, these issues may restrain the expansion of the worldwide market.

Moreover, a research report published in Italy in October 2020, on Clinical and Molecular Allergy found that doctors are having trouble treating patients with chronic conditions. As a result, telemedicine is used to treat or delay the majority of allergies.

Also, individuals with severe asthma cannot travel frequently due to the lack of facilities for in-person visits under emergency circumstances. The above factors indicate that the market has had little development during the pandemic period.

Key Findings of the Study

  • Based on test type, the in vivo sub-segment emerged as the global leader in 2021, and In vitro sub-segment is anticipated to be the fastest growing sub-segment during the forecast period.
  • Based on product/service, the consumable sub-segment emerged as the global leader in 2021, as well as it is anticipated to be the fastest growing sub-segment during the forecast period.
  • Based on allergen, the inhaled allergens sub-segment emerged as the global leader in 2021 and the food allergens sub-segment is anticipated to be the fastest growing sub-segment during the forecast period.
  • Based on end-user, the diagnostic laboratories sub-segment emerged as the global leader in 2021, as well as it is predicted to show the fastest growth in the upcoming years.
  • Based on region, the North America market registered the highest market share in 2021 and the Asia-Pacific market is predicted to show the fastest growth in the upcoming years.
  • The study provides in-depth analysis of the Allergy Diagnostics Market share across the various regions.

Companies Mentioned

  • Alerchek Inc.
  • Danaher Corp
  • Hitachi chemical Diagnostic Inc.
  • HOB Biotech Group Co. Ltd.
  • Hycor Biomedical Inc.
  • Lincoln Diagnostics Inc.
  • Omega Diagnostic Llc
  • Siemens Healthcare Diagnostics, Inc.
  • Stallergenes SA
  • Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher
  • Omega Diagnostics Group PLC
  • Eurofins Scientific
  • bioMérieux SA
  • HollisterStier Allergy
  • Minaris Medical America, Inc.
  • ACON Laboratories, Inc.
  • Lincoln Diagnostics, Inc.
  • Neogen Corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...